Yesterday completed the first 2 consecutive down days since mid April on the SPY, although the market did try and recover and close green. Today the futures are red once again, following Europe and Asia’s action. The Nikkei once again proved to be extremely volatile, starting up over 3%, and then tumbled down 4%, and finally closed up .9%.
With the three-day weekend coming, will be interesting to see how today pans out.
Gold and Silver have found a bit of footing, but I continue to think it will be short lived. ISRG had a favorable verdict yesterday, and the stock is up nearly 4% pre-market, will see if the move has any follow through.
Here are the analyst changes for today:
|CRM Salesforce.com weakness a buying opportunity, says Susquehanna|
|Susquehanna would use any weakness in Salesforce.com as a buying opportunity. The firm cited increased guidance and an evolving business model. shares are Positive rated with a $50 price target|
|CRM Salesforce.com weakness a buying opportunity, says Barrington|
|Barrington says it views any weakness in shares of Salesforce.com following the company's Q1 results as a buying opportunity. The firm believes Salesforce.com is a growth company that will deliver plenty of profitability once growth slows and keeps an Outperform rating on the stock|
|CRM Salesforce.com pullback a buying opportunity, says Lazard Capital|
|Lazard Capital views the post earnings pullback in shares of Salesforce.com as a buying opportunity and reiterates a Buy rating on the stock with a $52.50 price target|
|CRM Salesforce.com results solid, says Stifel|
|After Salesforce.com reported higher than expected Q1 revenue and provided roughly in-line guidance, Stifel thinks the results were "solid but not flashy." The firm believes that the company is likely to report stronger results later in the year, and it keeps a Buy rating on the shares|
|ISRG Intuitive Surgical risk decreased by court decision, says Cantor|
|After Intuitive Surgical won the first of 26 cases alleging that patients' injuries or deaths were caused by the company's da Vinci robotic surgery product, Cantor thinks the decision indicates that the cases will not greatly damage the company's reputation. The firm reiterates a $575 price target and Buy rating on the stoc|
|P Pandora price target raised to $24 from $20 at Piper Jaffray|
|Piper Jaffray raised its estimates and price target for Pandora citing the company's strong Q1 results and improving monetization. The firm keeps an Overweight rating on the stock|
|CRM Salesforce.com downgraded at Wedbush|
|As previously reported, Wedbush downgraded Salesforce.com to Neutral from Outperform. The firm downgraded shares due to the significant decline it Q1 deferred commission expenditures, an indication that new sales activity in the quarter was down substantially. Price target lowered to $42 from $51|
May look to get some more OPEN positions today, as well as possibly playing some TSLA calls for a possible $100 break. Folks are asking me about ISRG and my thoughts, think it will be hard to get a good position with the large spreads and high premiums, but stay tuned to chat and twitter for updates.
Here are the strikes I am looking at for the open:
|Stock Ticker||Call/Put||Strike||Expiration||Closing Price||Entry Price|
Dont forget the week ahead Sunday night at 10:30 : https://www.optionmillionaires.com/live-event-classes-jtv/
Lets have a great end to the week and EVERYONE HAVE A GREAT Holiday WEEKEND!!